QA: Athenex Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001300699_2023_Athenex_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001300699')"}

Graph

Absolute values for 0001300699, Athenex Inc.

  xvar xval
0 AssetsCurrent 124,929,000
1 IntangibleAssetsNetIncludingGoodwill 72,112,000
2 PropertyPlantAndEquipmentNet 1,824,000
3 remainder_Assets 5,190,000
4 LiabilitiesCurrent 114,879,000
5 LiabilitiesNoncurrent 5,782,000
6 remainder_Liabilities 107,575,000
7 CostOfGoodsAndServicesSold 76,118,000
8 SellingGeneralAndAdministrativeExpense 44,880,000
9 ResearchAndDevelopmentExpense 51,758,000
10 remainder_Expenses 26,269,000
11 remainder_Revenues 102,821,000
12 remainder_NetIncome -8,219,000
13 remainder_ComprehensiveNetIncome 2,370,000
  yvar yval
0 Assets 204,055,000
1 Liabilities 228,236,000
2 Expenses 199,025,000
3 Revenues 102,821,000
4 StockholdersEquity -24,181,000
5 NetIncome -104,423,000
6 ComprehensiveNetIncome -103,238,000
7 BaseVar 372,363,000
8 EconomicCapitalRatio -0.670

Edgar->Model Mapping

Feature Distribution

Change over Time